GSK appoints senior vice president and general counsel

GlaxoSmithKline (GSK) has appointed Dan Troy to the position of senior vice president and as a general counsel to its global pharmacy supply operations.

Mr Troy’s main responsibilities will be to advise the company on how best to approach litigation issues and drug approval procedures worldwide.

He is deemed to be highly qualified for the position because of his time spent as the chief counsel at the US Food and Drug Administration (FDA).

In this role he had to be fully familiar with many of the most crucial legal questions impacting the pharmaceutical supply industry around the world, GSK has explained.

Andrew Witty, GSK’s chief executive, said: “Dan shares our vision that it is critical in today’s healthcare environment that we deliver differentiated products of real value to patients and payors.

“His wealth of experience in the regulatory legislative area will be of enormous benefit to us and ultimately to patients.”

GSK has recently pointed to simplification of its operating model and global diversification as being among its primary strategic goals for the coming year.